Provided are novel organic molecules containing fused indole and benzimidazole moieties, or their boron containing analogs. Also provided are OLEDs and related consumer products that utilize these compounds containing the fused indole and benzimidazole moieties.

Provided are novel organic molecules containing fused indole and benzimidazole moieties, or their boron containing analogs. Also provided are OLEDs and related consumer products that utilize these compounds containing the fused indole and benzimidazole moieties.

Disclosed are a heterocyclic compound represented by Formula 1-1 or 1-2,

##STR00001## wherein, in Formulae 1-1 and 1-2, X.sub.1, CY.sub.1 to CY.sub.3, R.sub.1 to R.sub.3, and a1 to a3, are the same as described in the specification. Also disclosed is an organic light-emitting device including the same.

Disclosed are a heterocyclic compound represented by Formula 1-1 or 1-2,

##STR00001## wherein, in Formulae 1-1 and 1-2, X.sub.1, CY.sub.1 to CY.sub.3, R.sub.1 to R.sub.3, and a1 to a3, are the same as described in the specification. Also disclosed is an organic light-emitting device including the same.

A tetra-aza corand compound of formula (Ia) and compound of formula (Ib) and salts thereof. The tetra-aza corand of formula (Ia) and (Ib) of the present invention relates to novel corand entity having a substantially enclosed volume and a framework structure, the compounds are designed as therapeutic carriers for molecule therapeutics delivery and pharmaceutical compositions thereof.

A tetra-aza corand compound of formula (Ia) and compound of formula (Ib) and salts thereof. The tetra-aza corand of formula (Ia) and (Ib) of the present invention relates to novel corand entity having a substantially enclosed volume and a framework structure, the compounds are designed as therapeutic carriers for molecule therapeutics delivery and pharmaceutical compositions thereof.

Provided is a compound having higher fluorescence quantum yield and higher optical stability than a conventional FLAP and a polymer compound containing the compound. ##STR00001## A: seven or eight-membered ring structure, Y.sup.1, Y.sup.2, Y.sup.3: halogen atom or the like, a1: number of Y.sup.1, a2: number of Y.sup.2, B: number of Y.sup.3, 0≤m and n≤3: when 1≤m≤3, Y.sup.1 may be substituted with a structure portion defined by m, when 1≤n≤3, Y.sup.2 may be substituted with a structure portion defined by n, and B.sup.1, B.sup.2: Formulas (2-1) to (2-3). ##STR00002## C.sup.1, C.sup.2, C.sup.3: structure containing a cyclic hydrocarbon compound, D.sup.1, D.sup.2, D.sup.3: substructure that inhibits aggregation, E.sup.1, E.sup.2, E.sup.3: polymerizable substructure, Z.sup.1: hydrogen atom or the like, c: number of substituent groups Z.sup.1, Z.sup.2, Z.sup.3: hydrogen atom or the like, and may form a ring with C.sup.2.

Provided is a high-stability ion-selective membrane (ISM) containing a thallium porphyrin complex as an ionophore, the ISM containing: a compound represented by the following formula (1); a polymer; and a membrane solvent.

##STR00001##

Provided is a high-stability ion-selective membrane (ISM) containing a thallium porphyrin complex as an ionophore, the ISM containing: a compound represented by the following formula (1); a polymer; and a membrane solvent.

##STR00001##

M-phthalocyanine nanowires according to the present invention can have a variety of uses as the M-phthalocyanine nanowires can control the crystalline structure thereof by controlling the flow speed of a carrier gas to a suitable range, and can exist in hydrophilic solvent without agglutinating due to superb dispersibility in water.